KENDRA LATTY: Open Payments
NPI 1659763589 · COSTA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,076 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $116 · 2025 $1,076
Food & beverage: $1,076
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $198 |
| Otsuka America Pharmaceutical, Inc. | 1 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $129 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $112 |
Products named: REXULTI, CAPLYTA, Auvelity, VRAYLAR, INGREZZA, COBENFY, INVEGA TRINZA, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
